Nicholas Jackson Location
Denmark
Nicholas Jackson Work
- 2025 - now President of Global R and D and Alliances @ Clover Biopharmaceuticals
- 2024 - now Chief Executive Officer and Executive Director @ Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI)
- 2022 - 2024 President of Global Research and Development @ Clover Biopharmaceuticals
- 2019 - 2022 Head of Programs and Technology, Vaccine R and D; Managing Director of Shanghai Office. @ CEPI (Coalition for Epidemic Preparedness Innovations)
- 2016 - 2019 VP, Head of Global Research @ Sanofi
- 2013 - 2015 AVP, R and D; Head of R and D for Sanofi's Dengue Vaccine company @ Sanofi
- 2011 - 2013 Senior Director, Vaccine Research and Early Development @ Pfizer
- 2010 - 2011 Senior Director, Vaccine R and D Emerging Markets @ Pfizer
- 2009 - 2011 Sr Director, Project Leader, Immunotherapeutics (J and J and Pfizer strategic partnership) @ Pfizer
- 2007 - 2010 Senior Director, Project Leader, Vaccine and Immunotherapeutic R and D @ Pfizer
Nicholas Jackson Education
- University of Warwick
PhD (Viral Immunology)
1994 - 1998 - London School of Hygiene and Tropical Medicine, U. of London
Master’s Degree (Molecular Biology, Infectious Diseases)
1993 - 1994 - Oxford Brookes University
Bachelor of Science - BS (Cell and Molecular Biology)
1990 - 1993
Nicholas Jackson Skills
- Vaccines
- Pharmaceutical Industry
- Clinical Development
- Drug Development
- Infectious Diseases
- Clinical Trials
- Biotechnology
- Biopharmaceuticals
- Drug Discovery
- CRO
Nicholas Jackson Summary
Nicholas Jackson, based in Denmark, is currently a President of Global R and D and Alliances at Clover Biopharmaceuticals. Nicholas Jackson brings experience from previous roles at Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI), Clover Biopharmaceuticals, CEPI (Coalition for Epidemic Preparedness Innovations) and Sanofi Pasteur. Nicholas Jackson holds a 1994 - 1998 PhD in Viral Immunology @ University of Warwick. With a robust skill set that includes Vaccines, Pharmaceutical Industry, Clinical Development, Drug Development, Infectious Diseases and more. Nicholas Jackson has 2 emails on RocketReach.
5 free lookup(s).
No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Looking for a different Nicholas Jackson?
Find contact details for 700 million professionals.
Others Named Nicholas Jackson
-
32
-
Nicholas Jackson
Founder at Vicious Studio
New York, NY, US22 -
Nicholas Jackson
Managing Partner at Fitness 19
Midland Park, NJ, US31 -
21
-
Nicholas Jackson
Vice President of Cyber Thaumaturgy at Parsons Corporation
Washington, DC, US43
Top Clover Biopharmaceuticals Employees
-
Sophia Xu
Head of Finance, VP at Clover Biopharmaceuticals
Chengdu, Sichuan, China2 -
2
-
21
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5
free lookups.
Search the #1
Contact Database
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Use our
AI-Powered
Email Finder
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.
G2Crowd Trusted
300K+
Plugin Users
